Member Info for MR.Spacetomato

Afamaman,

Pardon my language, but I know we can pack alot of affimers in the LFA and get some great sensitivity, I think we will be able to beat the bejesus out of the Israelis on this test.

You are both welcome, shan and Hypermarlin.

As it seems we are up against Todos Medical with an almost identical test and are head to head. I am not afraid as we have enough market for everyone. And we are both mentioned.

Get avacta... because you are worth it!

C&En: We are the world's most comprehensive and authoritative news source about chemistry and related fields. Our journalists are based in Europe, the U.S., and Asia, and chemists recognize us for our breaking-news coverage and award-winning features. C&EN has been published by the American Chemical Society since 1923.

https://cen.acs.org/analytical-chemistry/diagnostics/Saliva-tests-show-promise-widespread/98/web/2020/08

Get Avacta...because you are worth it.

Thanks, PL75. Maybe I am reading too much into it. Thank you...( and as Wilson turns around and looks back at PL75 in a ponderous fashion as he takes his cuban cigar from his mouth he asks) ...Just one more thing...

I was just looking at BBI's statement again (thanks gmcc for the post) and at this specific paragraph and its relation to the Portan Down labs assessment:

"Avacta aims to begin clinical validation of the test as soon as possible by using the first pilot batches generated as part of the technology transfer process for these studies. In parallel with these clinical validation studies, which will be run within the UK government’s CONDOR programme and potentially with other collaborators globally, BBI will work with Avacta and Cytiva to produce the additional technical documentation that is required for CE marking of the final product."

Is there the missing link we were looking for? And if so, the point where it says "..other collaborators globally" could signify that BBI's base in the USA could be working with the FDA as we speak assessing our test?

Just wondering..

ST

Vaccine against smurfiness, for me there for me, there is only one, and it can be developed quickly and I will take it, but it must contain affimers in the recipe; affimers to cling on to the smurff virus and affimers to get the damn medication out of me as quickly as possible!

Wilson

CaptainStanley, your friends at ODX got an RNS and are down? If I were you I would keep myself away from there for a while.

Friendly advice

ST

Yesterday I thought to increase a little bit my holding on SNG so I did a little swing trade by selling it at 244.5 and buying into AVCT at 179.9 when it dropped a little, and then was going to sell that and buy back SNG today when it dropped (242 at one point). I don't like being 100% in one company, but how does greed work wonders sometimes!

..and me talking about releasing the spinnaker! Doh

GLR1990, wait till we get the spinnaker released! We will need all hands dealing with the ropes!

Ok, just threw the charts in the bin. Yeaaaah!

ST

Wiggly, my chart target mentioned 2 days ago said 200p..not more! ;o)

Spike66, we are in the Condor programme and mentioned by the Government website. It would be unthinkable not to have our LFT being assessed by the Government Lab together with other tests as our is ready. And the description by the Sir John Bell matches ours in my view:

Pregnancy type LFA
£5 quid a pop
10 minutes results
Antigen
High specificity and sensitivity

sT

Visainn, good morning.

I was wondering why you are predicting that? Is it based in what exactly? Are you basing your prediction on the day of the rush from investors trying to buy it on the day?

We all have our targets to sell. We have heard all sorts of prices here; from your 3 to 20 and even more in the long future or on a takeover approach. You take you pick.

I was trying to imagine what sort of income we may get from the LFA sales alone (not even including BAMS, integumen or the other JV currently in motion). I was trying to be conservative on the sale price of the LFA at £5 which Avacta getting £2, or thereabouts and based on a possible order from the UK government alone. Please, forgive my amateur ways here, but imagining we get an initial order for 50 million tests at £5, from which we get £2, that would be £100 million for Avacta.

We have about 26 european countries and say half of them order the same, that would be £1,3 billion.

What about for the rest of the world?

The question now stands...when do I sell, dude? Am I going to be a long termer here and see through a potential takeover or see Avacta become a global player?

I wonder what that feels like for that guy who sold the recipe of Coca Cola for pocket change and later saw it go global making the dude that bought it mega rich?

Food for thought.

ST

The LumiraDx SARS-CoV-2 Ag Test can be used
to test nasal swab samples directly using a dual
nares collection (swab inserted in both nares).
• The LumiraDx SARS-CoV-2 Ag Test should be
ordered for the detection of COVID-19 in
individuals who are suspected of COVID-19 by
their healthcare provider and who are within the
first twelve days of onset of symptoms.

The LumiraDx SARS-CoV-2 Ag Test is only
authorized for use in laboratories in the United
States.

NAaahh

Sorry if posted before:

https://www.youtube.com/watch?v=WYpiFJJPP4s

Roll call now...See you all tomorrow.

ST

DOH, Wilson got this funny look on his leather face after your porridge reference. He's told me he's still in touch with Jesus and Vasques from the gaol! They may pay a "visit" to you one of them days to, I paraphrase here..."toss your salad".

ST

Seadogsteve, that batch he will get when he goes to the Pub!

PL75, now we need DOH to get the syntax of that one for the final evaluation. Another one to be Avacted!

W.